20 Oct

FDA moves to pull generic Concerta from market

Makers have 30 days to call for hearing and prove drugs work the same as brand-name Oct. 20, 2016 – San Diego, CA -- The makers of two generic versions...

20 Oct

Zofran maker attempts to get lawsuits dismissed in three separate motions

Oct. 19, 2016 – San Diego, CA -- GlaxoSmithKline is urging a Massachusetts federal court to dismiss some or all claims lodged against the company and its anti-nausea drug Zofran,...

19 Oct

Janssen appeals $76M Risperdal verdict

Pharmaceutical company argues verdict was “blatantly excessive;" plaintiffs challenge court order preventing punitive damage awards Oct. 18, 2016 – San Diego, CA -- Janssen Pharmaceuticals appealed a $70 million verdict awarded...

17 Oct

Mo. judge denies J&J’s bid for mistrial in third St. Louis talc trial

Oct. 17, 2016 – San Diego, CA -- A Missouri judge denied another attempt by Johnson & Johnson to halt proceedings in the third talcum powder lawsuit to go before...

15 Oct

JAMA study: IVC filters may actually be riskier for trauma patients

Oct. 14, 2016 – San Diego, CA -- A new study shows IVC filters provide no additional life-saving benefits to trauma patients at risk for blood clots. The single-center study,...

14 Oct

Could FDA’s re-analysis of Xarelto study affect ongoing litigation?

Oct. 14, 2016 – San Diego, CA -- This week, the U.S. Food and Drug Administration posted the conclusion of its re-analysis of the ROCKET AF trial, which helped propel...

14 Oct

Bravelle class action survives Ferring’s attempt to dismiss

Oct. 13, 2016 – San Diego, CA -- A class action lawsuit against the makers of the fertility drug Bravelle survived the manufacturer’s attempt to quash it last month. Plaintiffs...

12 Oct

FDA study finds Xarelto puts patients at increased risk for bleeding compared to Pradaxa

Oct. 12, 2016 – San Diego, CA -- A new study by the U.S. Food and Drug Administration published this month in JAMA Internal Medicine shows patients taking the blood-thinning...

11 Oct

FDA says recalled blood monitoring device did not affect Xarelto trial results

  Oct. 11, 2016 – San Diego, CA – “No changes in rivaroxaban labeling … are warranted. No other major regulatory action should be taken with respect to rivaroxaban,” the...

10 Oct

Plaintiffs seek to consolidate Invokana suits in state, federal courts

Oct. 10, 2016 – San Diego, CA -- Plaintiffs suing the makers of the diabetes drug Invokana are looking to consolidate lawsuits in both state and federal courts, The Legal...

Categories

Recent post

What Our Clients Say